Henock Yebyo completed his PhD in 2018 in the structured PhD program “Epidemiology and Biostatistics” at the University of Zurich. He previously finished
his master’s degree in Biostatistics and Health Informatics at Mekelle University
in collaboration with Tulane University. From 2009 to mid 2015, he had worked for Mekelle University in different academic ranks where he also led and participated
in research projects of different areas, including reproductive health issues, NCDs, nutrition, diagnostic test, and mHealth. In January 2019, Henock continued working
at the Epidemiology, Biostatistics and Prevention Institute (EBPI) as postdoctoral fellow focusing on different Swiss Medical Board prioritized research areas, particularly on Health Technology Assessment and/or benefit harm analysis of systematic early rehabilitation in ICU, cancer drugs, and robotic surgery. His research interests lie in prevention strategies of NCDs and benefit-harm analysis of medical and public health interventions.